Baseline and on-study variables that predict 15-year disease activity in patients with CIS treated with interferon beta-1b in the BENEFIT trialL. Kappos,M. S. Freedman,G. Edan,X. Montalban,H. -P. Hartung,F. Barkhof, R. Koelbach,E. -M. WickleinMULTIPLE SCLEROSIS JOURNAL（2019）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
